TWiV 1014: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status, smart thermometer–based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic, COVID-19 vaccine mandates, changing severity and epidemiology of adults hospitalized with COVID-19 in the United States after introduction of COVID-19 vaccines, effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. veterans, national trends in anticoagulation therapy for COVID-19 hospitalized adults in the United States, development of a definition of postacute sequelae of SARS-CoV-2 infection, neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms, long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms, and coronary microvascular health in symptomatic patients with prior COVID-19 infection.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Estimates of SARS-CoV-2 seroprevalence and incidence of infections among blood donors, by vaccination status (CDC)
• Smart thermometer–based surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic (JAMA)
• COVID-19 vaccine mandates (GOV)
• Changing epidemiology of adults hospitalized with COVID-19 after introduction of vaccines (CID)
• Effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. Veterans (ACP Journals)
• National trends in Anticoagulation therapy for COVID-19 (IDSA)
• Development of a definition of postacute sequelae of SARS-CoV-2 infection (JAMA)
• Neuroinflammation after COVID-19 with depressive and cognitive symptoms (JAMA)
• Long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms (OFID)
• Coronary microvascular health in patients with prior COVID-19 infection (EACVI)
• Contribute to our FIMRC fundraiser at PWB
• Letters read on TWiV 1014
• Dr. Griffin's COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]